title: Evaluation of rubella screening in pregnant women.
abstract: BACKGROUND
  The rationale for rubella vaccination in the general population and for screening for rubella in pregnant women is the prevention of congenital rubella syndrome. The objective of this study was to evaluate the effectiveness of the prenatal rubella screening program in Quebec.
  
  
  METHODS
  A historical cross-sectional study was designed. Sixteen hospitals with obstetric services were randomly selected, 8 from among the 35 "large" hospitals in the province (500 or more live births/year) and 8 from among the 50 "small" hospitals (fewer than 500 live births/year). A total of 2551 women were randomly selected from all mothers of infants born between Apr. 1, 1993, and Mar. 31, 1994, by means of stratified 2-stage sampling. The proportions of women screened and vaccinated were ascertained from information obtained from the hospital chart, the physician's office and the patient.
  
  
  RESULTS
  The overall (adjusted) screening rate was 94.0%. The rates were significantly different between large and small hospitals (94.4% v. 89.6%). Five large hospitals and one small hospital had rates above 95.0%. The likelihood of not having been screened was statistically significantly higher for women who had been pregnant previously than for women pregnant for the first time (4.8% v. 1.4%; p < 0.001). Of the 200 women who were seronegative at the time of screening (8.4%), 79 had been vaccinated postpartum, had a positive serological result on subsequent testing or did not require vaccination, and 59 had not been vaccinated postpartum; for 62, subsequent vaccination status was unknown.
  
  
  CONCLUSIONS
  Continued improvement in screening practices is needed, especially in small hospitals. Because vaccination rates are unacceptably low, it is crucial that steps be taken to address this issue.
authors.affiliation: Division of Clinical Epidemiology, Montreal General Hospital, Que. gyorkost@who.ch
authors.forename: T W
authors.initials: TW
authors.lastname: Gyorkos
authors.forename: T N
authors.initials: TN
authors.lastname: Tannenbaum
authors.forename: M
authors.initials: M
authors.lastname: Abrahamowicz
authors.forename: G
authors.initials: G
authors.lastname: Delage
authors.forename: J
authors.initials: J
authors.lastname: Carsley
authors.forename: S
authors.initials: S
authors.lastname: Marchand
mesh_terms: D002170:Canada; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008403:Mass Screening; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis*; D012409:Rubella / Q000175:diagnosis*; D012410:Rubella Syndrome, Congenital / Q000517:prevention & control*; D014611:Vaccination